190 related articles for article (PubMed ID: 9789703)
1. Doxorubicin-induced cardiomyopathy treated with carvedilol.
Fazio S; Palmieri EA; Ferravante B; Bonè F; Biondi B; Saccà L
Clin Cardiol; 1998 Oct; 21(10):777-9. PubMed ID: 9789703
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
Rusconi P; Gómez-Marín O; Rossique-González M; Redha E; Marín JR; Lon-Young M; Wolff GS
J Heart Lung Transplant; 2004 Jul; 23(7):832-8. PubMed ID: 15261177
[TBL] [Abstract][Full Text] [Related]
3. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
Tatli E; Kurum T
Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
[TBL] [Abstract][Full Text] [Related]
4. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
Huang M; Zhang X; Chen S; Sun Y; Xiao Y; Sun J; Huang M; Chen S; Liu F
Pediatr Cardiol; 2013 Mar; 34(3):680-5. PubMed ID: 23108482
[TBL] [Abstract][Full Text] [Related]
5. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R
Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
[TBL] [Abstract][Full Text] [Related]
6. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
Kurum T; Tatli E; Yuksel M
Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794
[TBL] [Abstract][Full Text] [Related]
7. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
Metra M; Nodari S; Garbellini M; Boldi E; Rosselli F; Milan E; Giubbini R; Dei Cas L
Cardiologia; 1997 May; 42(5):503-12. PubMed ID: 9289367
[TBL] [Abstract][Full Text] [Related]
8. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
Metra M; Nardi M; Giubbini R; Dei Cas L
J Am Coll Cardiol; 1994 Dec; 24(7):1678-87. PubMed ID: 7963115
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience.
Bruns LA; Chrisant MK; Lamour JM; Shaddy RE; Pahl E; Blume ED; Hallowell S; Addonizio LJ; Canter CE
J Pediatr; 2001 Apr; 138(4):505-11. PubMed ID: 11295713
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol therapy in pediatric patients with dilated cardiomyopathy.
Askari H; Semizel E; Bostan OM; Cil E
Turk J Pediatr; 2009; 51(1):22-7. PubMed ID: 19378887
[TBL] [Abstract][Full Text] [Related]
11. [Is myocardial impairment in idiopathic dilated hypertrophic cardiomyopathy reversible by carvedilol?: a case report].
Ochiai N; Furukawa K; Ebizawa T; Yagi T; Akashi K; Nakamura T; Azuma A; Sugihara H
J Cardiol; 2000 Sep; 36(3):183-9. PubMed ID: 11022654
[TBL] [Abstract][Full Text] [Related]
12. Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
Malebranche R; Tabou Moyo C; Morisset PH; Raphael NA; Wilentz JR
Am Heart J; 2016 Aug; 178():151-60. PubMed ID: 27502863
[TBL] [Abstract][Full Text] [Related]
13. The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design.
Shaddy RE; Curtin EL; Sower B; Tani LY; Burr J; LaSalle B; Boucek MM; Mahony L; Hsu DT; Pahl E; Burch GH; Schlencker-Herceg R
Am Heart J; 2002 Sep; 144(3):383-9. PubMed ID: 12228773
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular reverse remodeling with infantile dilated cardiomyopathy and pitfalls of carvedilol therapy.
Tsuda E; Negishi J; Noritake K; Iwasa T; Abe T
J Cardiol; 2016 Feb; 67(2):147-52. PubMed ID: 26572957
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol.
Cohn LJ
N Engl J Med; 1999 May; 340(18):1443-4. PubMed ID: 10328713
[No Abstract] [Full Text] [Related]
16. Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure.
Palazzuoli A; Carrera A; Calabria P; Puccetti L; Pastrorelli M; Pasqui AL; Auteri A; Bruni F
Am Heart J; 2004 Jan; 147(1):E2. PubMed ID: 14691440
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F
J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
[TBL] [Abstract][Full Text] [Related]
18. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
19. [Reversibility of left ventricular dysfunction in elderly patients with dilated cardiomyopathy undergoing treatment with carvedilol. Report of a case].
Cioffi G; Stefenelli C
Ital Heart J Suppl; 2001 Jun; 2(6):668-72. PubMed ID: 11460842
[TBL] [Abstract][Full Text] [Related]
20. Treatment of dilated cardiomyopathy with carvedilol in children.
Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
